We recommend a HOLD on Zensar, aided by strong revenue growth momentum and better recovery. We assign a 10x P/E multiple to its FY24E earnings of Rs 22.1 per share to arrive at a TP of Rs 230/share, implying an upside of 6% from the CMP.